NDAINHALATIONGAS
Approved
Jun 2022
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
2/8 — Basic
Drug data last refreshed 19h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
OXYGEN, USP is a pharmaceutical-grade oxygen gas product administered via inhalation for therapeutic use in patients with hypoxemia and respiratory conditions. As a basic respiratory therapeutic gas, it functions to increase oxygen availability in the bloodstream and tissues. This is a foundational therapeutic agent across acute care, chronic disease management, and emergency medicine.
Peak
As a peak-lifecycle product with low competitive pressure (30%), this product maintains stable market presence with established distribution networks and limited growth opportunity for team expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
Started Jul 2026
39 enrolled
Bronchopulmonary DysplasiaPulmonary Hypertension
Safety Study of Intravenous Hydrogen-Oxygen Ultrafine Bubbles in Adults
Started May 2026
50 enrolled
Healthy Volunteer
MolecuLight All-in-One Oxygenation Clinical Utility
Started Mar 2026
20 enrolled
Wounds
Endoscopic COlorectal Mucosal Evaluation of Oxygen Tension
Started Mar 2026
80 enrolled
Anastomotic Leak RectumAnastomotic Leak Large Intestine
Impact of Intraoperative Oxygenation Practices on Patient Outcomes
Started Dec 2025
Worked on OXYGEN, USP at Universal Cells? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.